* Q2 Business net income up 4.2 percent, above expectations * Analyst says Toujeo sales “underwhelming” * CEO Brandicourt to unveil strategic plan on Nov.6, open to M&A * Shares […]

By Denise Roland The Wall Street Journal Biography @deniseroland [email protected] Updated July 30, 2015 7:51 a.m. ET AstraZeneca PLC on Thursday reported an increase in second-quarter revenue, thanks to proceeds […]

July 30, 2015By Mark Terry, BioSpace.com Breaking News Staff Reportedly, almost 200 former GlaxoSmithKline (GSK) employees who were transferred earlier this year to Parexel (PRXL) are being laid off today. […]

July 29, 2015By Alex Keown, BioSpace.com Breaking News Staff BOSTON – It’s been the year of deal making with more than $220 billion spent on mergers and acquisitions in the […]

By Tess Stynes The Wall Street Journal Biography @TessStynes [email protected] July 29, 2015 4:42 p.m. ET   Vertex Pharmaceuticals Inc. said its second-quarter revenue rose 20% on strong sales of […]

Gilead Sciences Inc. said its two key hepatitis C drugs, Sovaldi and Harvoni, generated about $4.9 billion in sales in the second quarter, topping Wall Street estimates, thanks to better-than-expected […]

GlaxoSmithKline moved to reclaim its prowess as a research powerhouse on Wednesday by flagging up dozens of new drugs and vaccines in development, as demand for new HIV medicines helped […]

The chairman of the board at Biogen has purchased more than $3 million worth of shares in the company, marking the first time a director or executive has bought the […]

Teva Pharmaceutical Industries may have found the deal it wanted in purchasing Allergan’s generics business for $40.5 billion in cash and stock, but the Israeli pharmaceutical company stands to lose around $300 […]

Anthem and Cigna, which announced a $54 billion merger on Friday morning, probably won’t be able to consummate their deal for at least a year. Regulators are beginning to closely scrutinize the two […]